Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

Stock Exchange Disclosures

Intimation of Postal Ballot Notice and Record date
Intimation of Investor call with ENAM Capital
Allotment of Shares - RSUs
Outcome of the Board Meeting _ Apil 24, 2024
Intimation for submission of appeal to the Commissioner of Income-tax
Intimation of receipt of the orders passed by the Deputy Commissioner of Income Tax (International Taxation)
Intimation of appointment of Nilanjan Roy as an Additional Director (Independent, Non-Executive)
Intimation of Investor call with FSSA Investment Managers
Intimation of Investor call with ICICI Prudential AMC
Intimation of Investor call with Fidelity Management & Research
Intimation of order imposing penalty
Update on the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
Intimation of rescheduling of meeting with Aberdeen Asset Management
Intimation for Loss of Share Certificate
Investor call with First State Investment stands cancelled
Investor call with ICICI Prudential AMC
Investor Call with Aberdeen Asset Management
Disclosure under Regulation 30(4) of the SEBI LODR
Investor call with DSP Mutual Fund
Investor call with First State Investment
Investor call intimation -Skerryvore Asset Management and Bajaj Allianz Life Insurance
Annual Disclosure by Large Corporate- May 11,2022
Allottment of Trust - April 27, 2022
Investor Meeting with APG Asset Management
Revision in Rating ICRA
Intimation regarding revision in rating under Regulation 30 of SEBI Listing Regulations.
Change in Directorate
Voting Result and Scruitinizer Report
Investor meeting with CLSA
Investor meeting with FSSA Investments and Edelweiss AMC
Update on Interim disbursements from Insurer towards the loss from fire incident reported in December 2016
Investor Call with FSSA Investment Managers
Investor Call with Bay Capital
Intimation of Schedule of Meetings with Institutional Investors
Advertisement in Newspapers – Financial Results Q3 FY21
Outcome of Board Meeting - Q3FY21
Intimation of Q3FY21 Investor Presentation
Q3FY21 Press Release-Intimation
Conference call for Analysts and Investors to be held on January 21,2021
Advertisement in Newspapers – Notice of Board Meeting to be held on January 20, 2021
Q4FY19 Board Meeting Intimation
Q4FY19 Press Release March 2019-Intimation
The Outcome of Board Meeting- Q4FY19
Investor Presentation March 2019- Intimation
Resignation of CS -Intimation
Investor Meetings with Pari Washington Company Advisors, Jefferies ASEAN and India Corporate Access Days, Axis Capital 12th Annual Conference, B and K Annual Conference
Investor Meeting with Canara Robeco Asset Management Company Ltd.
Investor Meeting with Seven Canyons Advisors
Postal Ballot Notice Intimation May 2019
Investor Meeting with Mondrian Investment Partners.
Sale of Share by Promoter to Achieve Minimum Public Shareholding
Completion of Sale of Shares by Promoter
Syngene Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services- Press Release
Intimation of AGM 2018
Intimation of AGM 2018: Newspaper Ad
Q1FY19 Board Meeting Intimation
The outcome of BM -Audited Financial Results Q1FY19
Investor Presentation June 2018- Intimation
Q1FY19 Press Release June2018-Intimation
Voting Results AGM July 2018
Investors Meetings- Dated till May 29th
Intimation of AGM 2017
Intimation of AGM 2017: Newspaper Ad
Board Meeting Intimation July27 2017
Board Meeting Intimation: Newspaper Ad
Intimation-Outcome of BM -Audited Financial Results
Syngene -Voting results under Regulation 44(3) of SEBI
Syngene 24th AGM Proceeding July 2017
Intimation-Outcome of BM -Audited Financial Results
New Appointment in Board
Board Meeting Intimation: 21st,July-2016
Financial Results Q1 FY17
Investors Meeting with Ambit Capital, SBI Life Insurance Co Ltd, Motilal Oswal 12th Annual Global Investor Confrence 2016, Motilal Oswal Roadshow in Asia , Axis Capital 10th Annual Conference
Syngene-SARC PressRelease,2016
Syngene strand PressRelease,2016
Investors Meeting with Dalal & Broacha Stock Broking Private Limited,Haitong Securities India Private Limited & Geneva Advisors, LLC
Board Meeting Intimation: 20th,October-2016
Board Meeting Intimation: Newspaper Ad
Investor Presentation-Oct2016
Investors Meeting with Mondrian Investment Partners, Mawer Investments, I Wealth Management, Templeton Asset Management Limited, Matthews India Fund, Marathon Asset Management, Matthews Asia
Syngene Postal Ballot Results - 2015
Intimation of Scheduled Meetings
Change in KMP
Interim Dividend Intimation to Stock Exchange
Syngene Dividend Declaration- March 2016
Investors Presentation at Jefferies India Corporate Day- March 2016
Investors Meeting with Karst Peak Capital, Batlivala &Karani, Cartica Capital
Investors Meeting with BlackRock UK, Nomura Securities, Ward Ferry Management Ltd
Investors Meeting with Nomura Securities is cancelled
Intimation of Board Meeting

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details